|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: Zofran for hyperemesisFrom: Henry Gregor (henrygregor@yahoo.com)Tue Jun 19 17:59:45 2007
Interesting phrasing re subbing...they're not the same risk profile. Both are category B for pregnancye, but hasn't much of the use of Anzemet been curtailed secondary to its potential for occasional, but significant, cardiac conduction/rhythm side effects, an effect not seen with zofran? I know anesthesiologists from two intitutions who say their groups use very little, if at all, of the Anzemet secondary to those concerns. Maybe oral vs parenteral Anzemet usage differs in risk.Maybe the folks I reference are being unduly cautious. (Whatever "unduly cautious" means, haha. I won't take offense if anyone wants to call that phrase worthless and undefineable.) Does the pharmacy do an informed consent re risk benefit, side effects potential with prescribing practitioners or patients receiving the substitution? Hank fran wilson <530rose@msn.com> wrote: Our hospital pharmacy subs anzamet for zofran, no iidea of the cost, but it seems effective. PEACE, Fran --------------------------------- Building a website is a piece of cake. --------------------------------- Yahoo! Small Business gives you all the tools to get online. -- ---------------------------------
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Thu Oct 2 04:56:52 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.